BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 25541214)

  • 1. Controlling measles using supplemental immunization activities: a mathematical model to inform optimal policy.
    Verguet S; Johri M; Morris SK; Gauvreau CL; Jha P; Jit M
    Vaccine; 2015 Mar; 33(10):1291-6. PubMed ID: 25541214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of measles supplementary immunization activities on reaching children missed by routine programs.
    Portnoy A; Jit M; Helleringer S; Verguet S
    Vaccine; 2018 Jan; 36(1):170-178. PubMed ID: 29174680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintaining high rates of measles immunization in Africa.
    Lessler J; Moss WJ; Lowther SA; Cummings DA
    Epidemiol Infect; 2011 Jul; 139(7):1039-49. PubMed ID: 20920382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
    Thompson KM; Badizadegan ND
    Risk Anal; 2017 Jun; 37(6):1109-1131. PubMed ID: 28561947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moving forward with strengthening routine immunization delivery as part of measles and rubella elimination activities.
    Fields R; Dabbagh A; Jain M; Sagar KS
    Vaccine; 2013 Apr; 31 Suppl 2():B115-21. PubMed ID: 23598472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health effects of routine measles vaccination and supplementary immunisation activities in 14 high-burden countries: a Dynamic Measles Immunization Calculation Engine (DynaMICE) modelling study.
    Auzenbergs M; Fu H; Abbas K; Procter SR; Cutts FT; Jit M
    Lancet Glob Health; 2023 Aug; 11(8):e1194-e1204. PubMed ID: 37474227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of an Intervention to Use a Measles, Rubella, and Polio Mass Vaccination Campaign to Strengthen Routine Immunization Services in Nepal.
    Wallace AS; Bohara R; Stewart S; Subedi G; Anand A; Burnett E; Giri J; Shrestha J; Gurau S; Dixit S; Rajbhandari R; Schluter WW
    J Infect Dis; 2017 Jul; 216(suppl_1):S280-S286. PubMed ID: 28838201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strengthening routine immunization through measles-rubella elimination.
    Biellik RJ; Orenstein WA
    Vaccine; 2018 Sep; 36(37):5645-5650. PubMed ID: 30041881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of supplemental measles immunization on cases of measles admitted at the Wesley Guild Hospital, Ilesa, Nigeria.
    Peter KB; Ademola AS; Oyeku OA
    Afr Health Sci; 2014 Mar; 14(1):131-5. PubMed ID: 26060469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Added value of the measles-rubella supplementary immunization activity in reaching unvaccinated and under-vaccinated children, a cross-sectional study in five Indian districts, 2018-20.
    Prosperi C; Thangaraj JWV; Hasan AZ; Kumar MS; Truelove S; Kumar VS; Winter AK; Bansal AK; Chauhan SL; Grover GS; Jain AK; Kulkarni RN; Sharma SK; Soman B; Chaaithanya IK; Kharwal S; Mishra SK; Salvi NR; Sharma NP; Sharma S; Varghese A; Sabarinathan R; Duraiswamy A; Rani DS; Kanagasabai K; Lachyan A; Gawali P; Kapoor M; Chonker SK; Cutts FT; Sangal L; Mehendale SM; Sapkal GN; Gupta N; Hayford K; Moss WJ; Murhekar MV
    Vaccine; 2023 Jan; 41(2):486-495. PubMed ID: 36481106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination strategies for measles control and elimination: time to strengthen local initiatives.
    Cutts FT; Ferrari MJ; Krause LK; Tatem AJ; Mosser JF
    BMC Med; 2021 Jan; 19(1):2. PubMed ID: 33397366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scheduling of measles vaccination in low-income countries: projections of a dynamic model.
    Bauch CT; Szusz E; Garrison LP
    Vaccine; 2009 Jun; 27(31):4090-8. PubMed ID: 19410622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of disruptions to routine vaccination programs, quantifying burden of measles, and mapping targeted supplementary immunization activities.
    Kostandova N; Loisate S; Winter A; Moss WJ; Giles JR; Metcalf CJE; Mutembo S; Wesolowski A
    Epidemics; 2022 Dec; 41():100647. PubMed ID: 36343498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost-effectiveness of supplementary immunization activities for measles: a stochastic model for Uganda.
    Bishai D; Johns B; Nair D; Nabyonga-Orem J; Fiona-Makmot B; Simons E; Dabbagh A
    J Infect Dis; 2011 Jul; 204 Suppl 1(Suppl 1):S107-15. PubMed ID: 21666151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the cost-effectiveness of different measles vaccination strategies for children in the Democratic Republic of Congo.
    Doshi RH; Eckhoff P; Cheng A; Hoff NA; Mukadi P; Shidi C; Gerber S; Wemakoy EO; Muyembe-Tafum JJ; Kominski GF; Rimoin AW
    Vaccine; 2017 Oct; 35(45):6187-6194. PubMed ID: 28966000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lessons learned in the implementation of supplementary immunization activity (SIA) field guidelines for injectable vaccines - Experiences from Tanzania.
    Mohamed N; Simba D; Mphuru A; Lyimo D; Kyesi F
    Vaccine; 2020 Nov; 38(49):7741-7746. PubMed ID: 33164797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measles control in Sub-Saharan Africa: South Africa as a case study.
    Verguet S; Jassat W; Hedberg C; Tollman S; Jamison DT; Hofman KJ
    Vaccine; 2012 Feb; 30(9):1594-600. PubMed ID: 22230581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of immunization control activities on measles outbreaks in middle and low income countries.
    Aylward RB; Clements J; Olivé JM
    Int J Epidemiol; 1997 Jun; 26(3):662-9. PubMed ID: 9222794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demographics, epidemiology and the impact of vaccination campaigns in a measles-free world - Can elimination be maintained?
    Prada JM; Metcalf CJE; Takahashi S; Lessler J; Tatem AJ; Ferrari M
    Vaccine; 2017 Mar; 35(11):1488-1493. PubMed ID: 28216186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of frequency and targeting of measles supplemental immunization activities in Nigeria: A cost-effectiveness analysis.
    Zimmermann M; Frey K; Hagedorn B; Oteri AJ; Yahya A; Hamisu M; Mogekwu F; Shuaib F; McCarthy KA; Chabot-Couture G
    Vaccine; 2019 Sep; 37(41):6039-6047. PubMed ID: 31471147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.